Table 2.
Overview of data assessing the prevalence of prediabetes and DM type 2 in stroke/TIA/ICH patients during the post-acute/chronic stroke phase (≥3 months after vascular event)
| Population | Vascular event | Glucose measurement | Number of patients | Normoglycemic, n (%) | Prediabetes, n (%) | DM type 2, n (%) |
|---|---|---|---|---|---|---|
| China | IS | OGTT | 111 | 64 (58) | 26 (23) | 21 (19) |
| Europe | IS, ICH | OGTT | 62 | 26 (42) | 23 (37) | 13 (21) |
| US | IS, TIA | FPG, OGTT | 98 | 44 (45) | 30 (31) | 24 (24) |
| Europe | IS | OGTT | 96 | 34 (35) | 26 (27) | 36 (38) |
| US | IS | FPG, OGTT | 80 | 30 (38) | 37 (46) | 13 (16) |
| South Africa | IS | FPG, OGTT | 44 | 26 (59) | 12 (27) | 6 (14) |
| China | IS | FPG, OGTT | 107 | 42 (39) | 37 (35) | 28 (26) |
| Total | 598 | 266 (44) | 191 (32) | 141 (24) |
Note: Reproduced from Fonville S, Zandbergen AA, Koudstaal PJ, den Hertog HM. Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management. Cerebrovasc Dis. 2014;37(6):393–400. Copyright © 2014 Karger Publishers, Basel, Switzerland.6
Abbreviations: DM, diabetes mellitus; TIA, transient ischemic attack; ICH, intracerebral hemorrhage; IS, ischemic stroke; OGTT, oral glucose tolerance test; FPG, fasting plasma glucose.